Evidence method
Level · gp.fundamentals.debt_to_revenue
153.59% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
LH · Sep 30, 2026
LABCORP HOLDINGS INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0000920148-26-000222General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.98% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.80% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
6.92% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
14.13% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
29.08% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
10.55% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.81% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Mar 31, 20190/6 normalizedLevel 3Jun 30, 20190/6 normalizedLevel 3Sep 30, 20190/6 normalizedLevel 3Dec 31, 20190/8 normalizedLevel 3Mar 31, 20200/7 normalizedLevel 3Jun 30, 20200/7 normalizedLevel 3Sep 30, 20200/7 normalizedLevel 3Dec 31, 20206/7 normalizedLevel 3Mar 31, 20216/7 normalizedLevel 3Jun 30, 20216/7 normalizedLevel 3Sep 30, 20216/7 normalizedLevel 3Dec 31, 20217/7 normalizedLevel 3Mar 31, 20226/6 normalizedLevel 3Jun 30, 20224/4 normalizedLevel 3Sep 30, 20227/7 normalizedLevel 3Dec 31, 20227/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20233/3 normalizedLevel 3Sep 30, 20234/4 normalizedLevel 3Sep 30, 20267/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 157.02%
- Current
- 153.59%
- Delta
- -3.42%
- Previous
- 3.53%
- Current
- 3.98%
- Delta
- 0.45%
- Previous
- 11.94%
- Current
- 14.80%
- Delta
- 2.86%
- Previous
- 5.78%
- Current
- 6.92%
- Delta
- 1.14%
- Previous
- 15.07%
- Current
- 14.13%
- Delta
- -0.94%
- Previous
- 29.80%
- Current
- 29.08%
- Delta
- -0.72%
- Previous
- 12.10%
- Current
- 10.55%
- Delta
- -1.55%
- Previous
- 0.94%
- Current
- 0.81%
- Delta
- -0.13%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 79%
- Compared
- 7 dimensions
- Coverage
- 100%
- Similarity
- 78%
- Compared
- 6 dimensions
- Coverage
- 86%
- Similarity
- 76%
- Compared
- 7 dimensions
- Coverage
- 100%
- Similarity
- 75%
- Compared
- 7 dimensions
- Coverage
- 100%
- Similarity
- 69%
- Compared
- 7 dimensions
- Coverage
- 100%
Research Graph
Related governed research
Compared To · Services-Medical Laboratories peers →Analogous To · LH state analogue 2 →Analogous To · LH state analogue 1 →Analogous To · LH state analogue 4 →Analogous To · LH state analogue 3 →Analogous To · LH state analogue 5 →Derived From · LH Company Quality Vector →Has State · LABCORP HOLDINGS INC. →Transitioned To · LH BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · LH CAPEX_INTENSITY_INCREASED →Transitioned To · LH CASH_GENERATION_INCREASED →Transitioned To · LH GROWTH_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.